Economic considerations associated with Pediculus humanus capitis infestation

Clinical Pediatrics

Volumn 43, Issue 6, 2004, Pages 523-527

  Hansen, Ronald C ^a   O'Haver, Judith ^a  

^a PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; LINDANE; MALATHION; NON PRESCRIPTION DRUG; PEDICULICIDE; PERMETHRIN; PRONTO SHAMPOO; PYRETHRIN; PYRETHROID; SHAMPOO; UNCLASSIFIED DRUG;

ABSENTEEISM; ACADEMIC ACHIEVEMENT; CHILD HEALTH CARE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DAY CARE; DEVICE; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DRUG CHOICE; DRUG COST; DRUG DOSE REGIMEN; DRUG UTILIZATION; ECONOMIC EVALUATION; HEALTH CARE COST; HUMAN; INFESTATION; LOTION; LOUSE; PEDICULUS; POLICY; PRESCRIPTION; REIMBURSEMENT; REVIEW; TREATMENT FAILURE; UNITED STATES;

ANIMALS; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DRUG COSTS; HUMANS; INFANT; INSECTICIDES; LICE INFESTATIONS; PEDICULUS; PYRETHRINS; SCALP DERMATOSES; UNITED STATES;

EID: 3242740247     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992280404300603     Document Type: Review

References (17)

1. Frankowski BL, Weiner LB. Committee on School Health the Committee on Infectious Diseases. American Academy of Pediatrics. Head lice. Pediatrics. 2002;110(3):638-643.
2. Meinking T, Taplin D. Infestations. In: Schachner LA, Hansen RC, eds. Pediatric Dermatology. 2nd ed. New York: Churchill Livingstone; 1995:1347-1392.
3. Clore ER, Longyear LA. Comprehensive pediculosis screening programs for elementary schools. J Sch Health. 1990;60(5):212-214.
4. Hansen RC. Guidelines for the treatment of resistant pediculosis. Contemp Pediatr 2000(suppl):4-10.
5. Steele RW. What has changed since the Red Book was published? Medscape Today. Available at: www.medscape.com/viewarticle/420210. Accessed August 20, 2003.
6. Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol. 2002;138:220-224.
7. Price JH, Burkhart CN, Burkhart CG, Islam R. School nurses' perceptions of and experience with head lice. J Sch Health. 1999;69(4):153-158.
8. Burkhart CN, Burkhart CG. Head lice revisited: characteristics, risk of fomite transmission, and therapy. J Clin Dermatol. 1999;2(2):15-18.
9. Zero Tolerance School Program. Available at: www.nitstripp.com/program. htm. Accessed August 20, 2003.
10. U.S. Bureau of Labor Statistics, Professional and Business Services average hourly earnings. Available at: data.bls.gov. Accessed August 21, 2003.
11. Pollack RJ, Kiszewski AE, Spielman A. Overdiagnosis and consequent mismanagement of head louse infestation in North America. Pediatr Infect Dis J. 2000;19:689-693.
12. Meinking TL, Entzel P, Villar ME, et al. Comparative efficacy of treatments for pediculosis capitis infestations: update 2000. Arch Dermatol. 2001;137 (3):287-292.
13. Burkhart CG, Burkhart CN. Clinical evidence of lice resistance to over-the-counter products. J Cutan Med Surg. 2000;4(4):199-201.
14. Pollack RJ, Kiszewski A, Armstrong P, et al. Differential permethrin susceptibility of head lice sampled in the United States and Borneo. Arch Pediatr Adolesc Med. 1999;153(9):969-973.
15. FDA Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Lice. Center for Drug Evaluation and Research. Available at: www.fda.gov/cder/drug/infopage/lindane/default.htm. Accessed June 5, 2003.
16. California Department of Health Services. State Health Director Offers Tips for Protecting Children From Head Lice. Sacramento: California Dept of Health Services; October 10, 2000. News release no. 54-00.
17. Jones KN, English JC. Review of common therapeutic options in the United States for the treatment of pediculosis capitis. Clin Infect Dis. 2003;36(1):1355-1361.